Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer

Journal of Urology

Volumn 186, Issue 5, 2011, Pages 1825-1829

  Porten, Sima P ^a   Whitson, Jared M ^a   Cowan, Janet E ^a   Perez, Nannette ^a   Shinohara, Katsuto ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biopsy; prostate; prostatic neoplasms; watchful waiting

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RISK; CANCER STAGING; EARLY CANCER; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TUMOR BIOPSY; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; TUMOR BURDEN;

EID: 80053956124     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.06.055     Document Type: Article

References (15)

1. G. Draisma, R. Etzioni, and A. Tsodikov Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context J Natl Cancer Inst 101 2009 374
2. R. Etzioni, D.F. Penson, and J.M. Legler Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends J Natl Cancer Inst 94 2002 981
3. L. Klotz Active surveillance for prostate cancer: a review Curr Urol Rep 11 2010 165
4. M.A. Dall'Era, M.R. Cooperberg, and J.M. Chan Active surveillance for early-stage prostate cancer: review of the current literature Cancer 112 2008 1650
5. C. Warlick, B.J. Trock, and P. Landis Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355
6. M.A. Dall'Era, B.R. Konety, and J.E. Cowan Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664
7. L. Klotz Active surveillance versus radical treatment for favorable-risk localized prostate cancer Curr Treat Options Oncol 7 2006 355
8. A.E. Ross, S. Loeb, and P. Landis Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program J Clin Oncol 28 2010 2810
9. M. Al Otaibi, P. Ross, and N. Fahmy Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance Cancer 113 2008 286
10. M.K. Ng, N. Van As, and K. Thomas Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time BJU Int 103 2009 872
11. M.I. Patel, D.T. DeConcini, and E. Lopez-Corona An analysis of men with clinically localized prostate cancer who deferred definitive therapy J Urol 171 2004 1520
12. A.J. Stephenson, A.G. Aprikian, and L. Souhami Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer Urology 59 2002 652
13. H.B. Carter, P.C. Walsh, and P. Landis Expectant management of nonpalpable prostate cancer with curative intent: preliminary results J Urol 167 2002 1231
14. T.B. Sheridan, H.B. Carter, and W. Wang Change in prostate cancer grade over time in men followed expectantly for stage T1c disease J Urol 179 2008 901
15. R.C. van denBergh, H. Vasarainen, and H.G. van derPoel Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study BJU Int 105 2010 956